Effect of biliary radiofrequency-ablation on patency rate of self-expanding metal stents

Status

Recruiting

Phases

Phase 4

Study type

Interventional

Source

DRKS

Registry ID

DRKS00018993

Enrollment

Registered

2020-09-01

Start date

2017-03-08

Completion date

Unknown

Last updated

2025-04-07

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

C24.8

Interventions

Group 1: Self-expandable-metal-stent-Implantion with Prior Radiofrequency-ablation. Group 2: Self-expandable-metal-stent-Implantion without Prior Radiofrequency-ablation.

Eligibility

Sex/Gender

All

Age

18 Years to No maximum

Inclusion criteria

Inclusion criteria: Histologically proofed malignant tumor with obstruction, compression or infiltration of the biliary tract. Biliary stenosis with clinical need for endoscopic intervention.

Exclusion criteria

Exclusion criteria: one of the mentioned intervention not applicable, uncontrolled biliary infection

Design outcomes

Primary

Measure	Time frame
Stent patency rate 6 months after application.	—

Secondary

Measure	Time frame
Occurance and frequency of complications (bleeding, infection, stent dislocation, gallstone formation) 6 months after stent application.	—

Countries

Germany

Contacts

Public ContactDavid Albers

Elisabeth-Krankenhaus Essen, Abteilung für Gastroenterologie

d.albers@contilia.de0201-897-3101

Outcome results

None listed

Source: DRKS (via WHO ICTRP) · Data processed: Feb 17, 2026